Services
Specializing in mid-market transactions, we advise private equity funds, corporate clients, and family-owned companies aiming to sell, divest, acquire, or merge businesses across international borders.
Acquisitions

Sales / Divestitures
Sectors
Specializing in mid-market transactions, we advise private equity funds, corporate clients, and family-owned companies aiming to sell, divest, acquire, or merge businesses across international borders.
Aerospace & Defence

Automotive

Business Services

Consumer Products
Energy & Mining

Food & Beverage

Healthcare & Pharmaceuticals

Industrials
Leisure

Maritime & Offshore

Packaging

Technology
Transactions
Advisors
Specializing in mid-market transactions, we advise private equity funds, corporate clients, and family-owned companies aiming to sell, divest, acquire, or merge businesses across international borders.
Please, choose your cross-border team

REACH M&A Advisory Firms
About us
Specializing in mid-market transactions, we advise private equity funds, corporate clients, and family-owned companies aiming to sell, divest, acquire, or merge businesses across international borders.
About

Insights

News

Contact

Fagron has acquired Central de drogas (Cedrosa)

Target Company Name:
Country:
Advisory:
Sector:
Partner:

Central de drogas (Cedrosa)
Mexico
Advisor to the seller
Healthcare & Pharmaceuticals
RIóN

The belgian group Fagron acquired CEDROSA, a leading supplier of raw materials (essentials) to the pharmaceutical and other industries in Mexico.

Central de drogas (Cedrosa)

Fagron

Sale of Cedrosa, supplier of raw materials to the pharmaceutical industries in Mexico, to the Belgian group Fagron

Advisor to the seller :
RIóN

Experts who worked on this transaction

Alexander von Griesheim

Alexander von Griesheim

REACH Operational Committee member Partner at RIóN

Eugenio Fernandez

Eugenio Fernandez

Partner at RIóN

Relevant transactions

Project Amygdala

Private Equity

Sale of mental health services provider for high-acuity individuals in the UK

Advisor to the seller :
Cooper Parry Corporate Finance

Genbio

Private Investors

Sale of a minority stake of Genbio, a hemoderivatives producer, to Private Investors

Advisor to the seller :
RIóN

icotec

MVM Partners

icotec, the world leader in the field of spinal tumor implants, has closed its USD 30m growth financing round led by MVM

Alpha Source Group

Probo Medical

Alpha Source Group, a portfolio company of Baird Capital, acquired by Probo Medical.

Advisor to the seller :
Brown Gibbons Lang & Company